BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15133815)

  • 41. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy.
    Brenneis C; Seppi K; Schocke MF; Müller J; Luginger E; Bösch S; Löscher WN; Büchel C; Poewe W; Wenning GK
    Mov Disord; 2003 Oct; 18(10):1132-8. PubMed ID: 14534916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neurophysiology of parkinsonian syndromes].
    Defebvre L; Cassim F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S62-74. PubMed ID: 12773890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration.
    Schofield EC; Caine D; Kril JJ; Cordato NJ; Halliday GM
    Mov Disord; 2005 Jan; 20(1):34-9. PubMed ID: 15390131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical correlates of similar pathologies in parkinsonian syndromes.
    Song YJ; Huang Y; Halliday GM
    Mov Disord; 2011 Feb; 26(3):499-506. PubMed ID: 21259341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased cortical inhibition induced by apomorphine in patients with Parkinson's disease.
    Manfredi L; Garavaglia P; Beretta S; Pellegrini G
    Neurophysiol Clin; 1998 Feb; 28(1):31-8. PubMed ID: 9562997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Limb apraxia in corticobasal degeneration and progressive supranuclear palsy.
    Soliveri P; Piacentini S; Girotti F
    Neurology; 2005 Feb; 64(3):448-53. PubMed ID: 15699373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy].
    Hattori M; Yoshida M; Ojika K; Yuasa H; Mitake S; Hashizume Y
    Rinsho Shinkeigaku; 2000 Apr; 40(4):372-7. PubMed ID: 10967656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ["Red flags": when to be alerted and how to explore?].
    Tison F
    Rev Neurol (Paris); 2010 Oct; 166(10):775-8. PubMed ID: 20817230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.
    Gilman S; Koeppe RA; Nan B; Wang CN; Wang X; Junck L; Chervin RD; Consens F; Bhaumik A
    Neurology; 2010 May; 74(18):1416-23. PubMed ID: 20439843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiologic patterns of oral-pharyngeal swallowing in parkinsonian syndromes.
    Alfonsi E; Versino M; Merlo IM; Pacchetti C; Martignoni E; Bertino G; Moglia A; Tassorelli C; Nappi G
    Neurology; 2007 Feb; 68(8):583-9. PubMed ID: 17310027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Gait and balance disorders in patients with atypical parkinsonian syndromes].
    Welter ML; Westby GW; Chastan N
    Rev Neurol (Paris); 2010 Feb; 166(2):188-95. PubMed ID: 19656539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing disease progression with MRI in atypical parkinsonian disorders.
    Köllensperger M; Wenning GK
    Mov Disord; 2009; 24 Suppl 2():S699-702. PubMed ID: 19877233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional mapping in PD and PSP for sustained phonation and phoneme tasks.
    Sachin S; Senthil Kumaran S; Singh S; Goyal V; Shukla G; Mahajan H; Behari M
    J Neurol Sci; 2008 Oct; 273(1-2):51-6. PubMed ID: 18675995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New and reliable MRI diagnosis for progressive supranuclear palsy.
    Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
    Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration.
    Josephs KA; Tang-Wai DF; Edland SD; Knopman DS; Dickson DW; Parisi JE; Petersen RC; Jack CR; Boeve BF
    Arch Neurol; 2004 Dec; 61(12):1881-4. PubMed ID: 15596608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Automated computer differential classification in Parkinsonian Syndromes via pattern analysis on MRI.
    Duchesne S; Rolland Y; Vérin M
    Acad Radiol; 2009 Jan; 16(1):61-70. PubMed ID: 19064213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice.
    Seppi K
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S400-5. PubMed ID: 18267272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.